Cart
sales@molnova.com
Home - Products - Chromatin/Epigenetic - COX - Hydroxytoluic acid

Hydroxytoluic acid

CAS No. 83-40-9

Hydroxytoluic acid( Hydroxytoluic acid | NSC 17561 | NSC17561 | NSC-17561 )

Catalog No. M16090 CAS No. 83-40-9

The salts or esters of salicylic acids, or salicylate esters of an organic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Hydroxytoluic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    The salts or esters of salicylic acids, or salicylate esters of an organic acid.
  • Description
    The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Hydroxytoluic acid | NSC 17561 | NSC17561 | NSC-17561
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    83-40-9
  • Formula Weight
    152.15
  • Molecular Formula
    C8H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC1=C(O)C(C(O)=O)=CC=C1
  • Chemical Name
    2,3-Cresotic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cummings AJ, Martin BK. Br J Pharmacol ChemOthers. 1965 Oct;25(2):470-80.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Sifalimumab

    Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNα and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.

  • Sudoxicam

    Sudoxicam is a reversible antagonist of COX with anti-inflammatory, anti-edema, and antipyretic properties.

  • Indobufen

    Indobufen is an inhibitor of platelet aggregation and is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes.

Sign In Join Free